An open label, non-controlled, multicentre, interventional trial to investigate the safety and efficacy of Canephron® N in the management of uncomplicated urinary tract infections (uUTIs)

Clinical Phytoscience

International Journal of Phytomedicine and Phytotherapy

Table 6 Changes in patients bacteriuria spectrum

	Day 0		Day 7		Day 37
	N	%	N	%	N	%
Patients	125	100	122	100	121	100
Patients with significant bacteriuria	65	52.0	65	53.3	61	50.4
Total isolates	87	100	83	100	79	100
E.coli	35	40.2	36	43.4	31	39.2
Klebsiella spp.	4	4.6	4	4.8	4	5.1
Proteus spp.	3	3.4	2	2.4	5	6.3
Other Enterobacteriaceae	1	1.1	3	3.6	2	2.5
Enterococci	34	39.1	28	33.7	32	40.5
Staphylococci	4	4.6	4	4.8	3	3.8
Streptococci	1	1.1	2	2.4	0	0.0
Other Gram positives	5	5.7	4	4.8	2	2.5

Number (N) and percentage (%) of patients with significant bacteriuria (≥ 10³ colony forming units (CFU)/ml) on Day 0, Day 7 and Day 37 and the respective spectrum of uropathogens